| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.3.CO;2-7 |
| P698 | PubMed publication ID | 10502265 |
| P2093 | author name string | Green S | |
| Ennis FA | |||
| Vaughn DW | |||
| Nisalak A | |||
| Kalayanarooj S | |||
| Nimmannitya S | |||
| Rothman AL | |||
| Suntayakorn S | |||
| P433 | issue | 3 | |
| P921 | main subject | Dengue virus | Q476209 |
| P304 | page(s) | 329-334 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Journal of Medical Virology | Q15716684 |
| P1476 | title | Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity | |
| P478 | volume | 59 |
| Q30250993 | 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response |
| Q40288450 | A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal |
| Q34353489 | An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. |
| Q34550268 | Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. |
| Q36628520 | Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy |
| Q91865140 | Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies |
| Q36487320 | Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients |
| Q26783659 | Biomarkers of severe dengue disease - a review |
| Q33785818 | Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients |
| Q40341836 | Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection |
| Q34500247 | Cellular and cytokine correlates of severe dengue infection |
| Q43195605 | Chikungunya fever, Hong Kong |
| Q33414050 | Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia |
| Q90443656 | Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017 |
| Q35551374 | Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans |
| Q36085940 | Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials |
| Q61803857 | Cytokine Signature Associated with Disease Severity in Dengue |
| Q34533363 | Cytokine expression profile of dengue patients at different phases of illness. |
| Q27481475 | Dengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF- ), and DV Infection Induces Altered Responsiveness to TNF- Stimulation |
| Q34117580 | Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection |
| Q34364315 | Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells |
| Q28278881 | Dengue virus life cycle: viral and host factors modulating infectivity |
| Q24673736 | Dengue virus selectively induces human mast cell chemokine production |
| Q33395882 | Dengue virus tropism in humanized mice recapitulates human dengue fever |
| Q27026302 | Dengue viruses - an overview |
| Q24609884 | Dengue: defining protective versus pathologic immunity |
| Q40516020 | Differential effects of dengue virus on infected and bystander dendritic cells |
| Q27469477 | Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections |
| Q27485633 | Elevated levels of soluble ST2 protein in dengue virus infected patients |
| Q36146301 | Elevated levels of vitamin D and deficiency of mannose binding lectin in dengue hemorrhagic fever |
| Q37711494 | Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever |
| Q33609685 | Evasion of the human innate immune system by dengue virus |
| Q27490377 | Gene Expression Profiling during Early Acute Febrile Stage of Dengue Infection Can Predict the Disease Outcome |
| Q33638451 | Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue |
| Q27481682 | High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection |
| Q37793734 | How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections |
| Q33430763 | Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity |
| Q39236667 | Immune-mediated cytokine storm and its role in severe dengue |
| Q37901360 | Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms |
| Q37743291 | Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity |
| Q40233196 | Increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes' mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication. |
| Q27472957 | Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge |
| Q33962671 | Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever. |
| Q34671059 | Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes |
| Q50049788 | Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome |
| Q34629343 | Mapping the interactions of dengue virus NS1 protein with human liver proteins using a yeast two-hybrid system: identification of C1q as an interacting partner |
| Q36305184 | Mathematical modelling and a systems science approach to describe the role of cytokines in the evolution of severe dengue |
| Q41722923 | Meta-analysis of biomarkers for severe dengue infections. |
| Q34746720 | Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q92242533 | Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease |
| Q40488687 | NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease |
| Q35206380 | Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome |
| Q21146686 | Predicting outcome from dengue |
| Q34345965 | Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans |
| Q35826280 | Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans |
| Q27477646 | Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis |
| Q27469685 | Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line |
| Q33430173 | SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation |
| Q27481677 | Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E |
| Q34048367 | Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever |
| Q34862804 | Serum IL-10 as a marker of severe dengue infection |
| Q33909193 | Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome |
| Q34500818 | Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. |
| Q63246534 | T-Cell Response to Viral Hemorrhagic Fevers |
| Q90021054 | T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection |
| Q40526154 | TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients |
| Q52345950 | The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3. |
| Q37713190 | The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome |
| Q27480996 | Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1 |
| Q33413903 | Vascular events in viral hemorrhagic fevers: a comparative study of dengue and hantaviruses |
| Q40167695 | Vascular leakage in dengue hemorrhagic Fever is associated with dengue infected monocytes, monocyte activation/exhaustion, and cytokines production |
Search more.